1. Miraglia D, Miguel LA, Alonso W. Esmolol in the management of pre-hospital refractory
ventricular fibrillation: A systematic review and meta-analysis. Am J Emerg Med.
2. Koster RW, Walker RG, Chapman FW. Recurrent ventricular fibrillation during
advanced life support care of patients with prehospital cardiac arrest. Resuscitation.
3. Gao D, Sapp JL. Electrical storm: definitions, clinical importance, and treatment. Curr Opin Cardiol. 2013;28:72-9.
4. Eifling M, Razavi M, Massumi A. The evaluation and management of electrical storm. Tex Heart Inst J. 2011;38:111-21.
5. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics—2019 Up- date: A Report From the American Heart Association. Circulation. 2019;139: e56–528.
6. Sakai T, Iwami T, Tasaki O, et al. Incidence and outcomes of out-of-hospital cardiac arrest with shock-resistant ventricular fibrillation: data from a large population-based cohort. Resuscitation. 2010;81:956–61.
7. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e272–391.
8. Wang CH, Huang CH, Chang WT, et al. Biphasic versus monophasic defibrillation in out-of-hospital cardiac arrest: a systematic review and meta-analysis. Am J Emerg Med. 2013;31:1472–8.
9. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346:884-90.
10. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J. 2002;19:57-62.
11. Driver BE, Debaty G, Plummer DW, Smith SW. Use of esmolol after failure of standard cardiopulmonary resuscitation to treat patients with refractory ventricular fibrillation. Resuscitation. 2014;85:1337–41.
12. Lee YH, Lee KJ, Min YH, et al. Refractory ventricular fibrillation treated with esmolol. Resuscitation. 2016;107:150–5.
13. Killingsworth CR, Wei CC, Dell'Italia LJ, et al. Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation. 2004;109:2469-74.
14. Jingjun L, Yan Z, Weijie, Dongdong Z, Guosheng L, Mingwei B. Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model. Resuscitation. 2009;80:1052-9.
15. Cammarata G, Weil MH, Sun S, Tang W, Wang J, Huang L. Beta1-adrenergic blockade
during cardiopulmonary resuscitation improves survival. Crit Care Med. 2004;32:
16. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in
survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336:1629–33.
17. Cheskes S, Dorian P, Feldman M, et al. Double sequential external defibrillation for refractory ventricular fibrillation: The DOSE VF pilot randomized controlled trial. Resuscitation. 2020;150:178-84.
18. Beck LR, Ostermayer DG, Ponce JN, Srinivasan S, Wang HE. Effectiveness of Prehospital Dual Sequential Defibrillation for Refractory Ventricular Fibrillation and Ventricular Tachycardia Cardiac Arrest. Prehosp Emerg Care. 2019;23:597-602.
19. Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396:1807-16.
20. Perkins GD, Ji C, Deakin CD, Quinn T, et al. PARAMEDIC2 Collaborators. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. N Engl J Med. 2018;379:711-21.
21. Mc KW, Gregg DE, Canney PC. Oxygen uptake of the nonworking left ventricle. Circ Res. 1958;6:612–23.
22. Berglund E, Monroe RG, Schreiner GL. Myocardial oxygen consumption and coronary blood flow during potassium-induced cardiac arrest and during ventricular fibrillation. Acta Physiol Scand. 1957;41:261–8.